Oklahoma AG Drummond alerts 23andME customers with tips
According to A.G. Gentner Drummond's office, 23andMe a genetic testing company collects and analyzes the genetic code of consumers.
'The implications of 23andMe selling genetic information to the highest bidder are understandably very concerning to Oklahomans who have used the company's services,' Drummond said. 'While the situation is troubling, there are easy steps that consumers can take to proactively safeguard their privacy.'
Oklahoma City's budget cuts affecting OKCPD
The Attorney General offers tips for interested consumers:
To delete genetic data from 23andMe
Log into your 23andMe account on its website.
Go to 'Settings' in your profile.
Scroll to the '23andMe Data' section at the bottom of the page.
Click 'View' next to '23andMe Data.'
Download your data. If you want a copy of your data for personal storage, select the option to download to your device before proceeding.
Scroll to the 'Delete Data' section.
Click 'Permanently Delete Data.'
You will receive an email from 23andMe to confirm the deletion request.
To destroy your 23andMe test sample
If you have opted to have your saliva sample and DNA stored by 23andMe but want to change that preference, you can do so on your account settings page, under 'Preferences.'
To revoke research consent regarding your genetic data
You can withdraw consent in research through your 23andMe account settings, under 'Research and Product Consents.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
5 days ago
- Forbes
Lions, Commanders, Bears Ticket Sales Spike Ahead Of 2025 Season
Ticket sales for the Detroit Lions, Washington Commanders and Chicago Bears show the biggest surge in price heading into the 2025 season when compared to last year, new data from ticket reseller Vivid Seats shows. Dylan Drummond of the Atlanta Falcons makes a reception and is tackled by Avonte Maddox #of the Detroit Lions during an NFL Preseason 2025 game Aug. 8, 2025. Getty Images Surging demand has driven up ticket prices for the Lions home and away games by 29% year over year on the platform, and prices are up 24% for the Commanders and 21% for the Bears. The Philadelphia Eagles and Minnesota Vikings also show increased demand, with a 17% and 16% increase in ticket prices from last year, respectively. Vivid Seats data show the Dallas Cowboys are the team with the most widespread fans, in 290 counties, more than any other team, followed by the Kansas City Chiefs (262 counties) and the Vikings (207 counties). When it comes to the most dedicated fans, the Eagles and Las Vegas Raiders lead—the Eagles have the most fans at away games, filling 47% of seats, and Raiders fans are willing to travel the furthest to see a game, averaging 575 miles per game last season. The NFC is the conference leading the market in demand for re-sale tickets, the Vivid Seats data shows, with an average sale price of $331, topping the AFC's $297. Get Forbes Breaking News Text Alerts: We're launching text message alerts so you'll always know the biggest stories shaping the day's headlines. Text 'Alerts' to (201) 335-0739 or sign up here : The Detroit Lions have seen a surge in popularity and fan engagement in recent years as the team rises in the rankings. The "Honolulu Blue wave" phenomenon, a reference to the team's signature color, has seen a surge in jersey sales, heightened social media activity and now a boost in ticket interest. The 2024-2025 season was the best in franchise history with an ending record of 15-2, a franchise record for wins, and saw them secure the NFC's No. 1 seed and a first-round bye. The Lions also had their best start since 1934. Going into the 2025 season, the Lions are the No. 2 seed in the NFC North. $131.82. That was the average NFL ticket price last regular season, up 9% from $120.94 the season before. What To Watch For If NFL sees a boost in broadcast viewers, too. The start of the 2024 season brought a viewership surge that shot the league to a nine-year high in television ratings, averaging 18.6 million viewers across the first three weeks. The viewership number was a significant boost from 2023's season's average of 17.9 million, which was itself the highest since 2015. The surge was attributed largely to the "Taylor Swift effect"—interest in her relationship with Kansas City Chiefs tight end Travis Kelce—bringing an influx of women and girls to the sport. The "Swift bump" increased viewership, jersey sales, and social media engagement. Other factors credited with contributing to the surge include the league's efforts to boost fan engagement, like licensing games to streaming services, the rise of sports betting and more participation in fantasy football. Further Reading Forbes The NFL's Most Valuable Teams 2024 By Justin Teitelbaum Forbes NFL Preseason Has New Meaning For Bengals, Colts, Jags, Vikings By Steve Silverman Forbes How To Play Fantasy Football (Guide For Beginners) By Steve Bradshaw
Yahoo
6 days ago
- Yahoo
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision Biologics, Danaher Corporation (Cepheid Inc.), GE HealthCare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., Biogen, QIAGEN, Genentech Inc., 23andMe Inc., Asuragen Inc and others. Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'US Personalized Medicine Market Size, Trends and Insights By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, Liver, Rheumatology), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Genetics, Liquid Biopsy, Others (Predictive Modeling, Imaging)), By End-user (Hospitals, Diagnostic Centers, Research & Academic Institutes), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' in its research database.'According to the latest research study, the demand of US Personalized Medicine Market size & share was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach a value of around USD 252.93 Billion by 2034, at a compound annual growth rate (CAGR) of about 17.32% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the US Personalized Medicine Market @ Overview As per the industry experts at CMI, the U.S. personalized medicine market is poised to witness a whopping CAGR in the forecast period. This could be attributed to genomic advancements such as next-generation sequencing that facilitate more accurate diagnostics and targeted therapies. The patients are asking for more customized approaches toward healthcare, thereby resulting in higher adoption of personalized medicine. Rise in incidences of chronic diseases such as cardiovascular diseases, cancer, and diabetes is accelerating the requirement of more personalized and effective treatment strategies. Conducive government policies coupled with raised funding for research and development activities are driving innovation. Key Trends & Drivers Technological Advancements and Higher Healthcare Spending to Spell Growth: Continuous advancements in data analytics, genomics, and bioinformatics are pushing the U.S. personalized medicine market forward. technologies such as CRISPR, NGS, and AI are transformingtreatment plans and diagnostics and making them more targeted as well as individualized. This innovation translates into patients' better understanding and customizes the treatment with better results. Also, as healthcare spending increases, the government as well as private agencies continue spending more dollars on the new technologies pertaining to modern medicine as mentioned above. Request a Customized Copy of the US Personalized Medicine Market Report @ Rise in Incidences of Chronic Diseases to Catalyze the U.S. Personalized Medicine Market: Chronic ailments cover conditions such as diabetes, cancer, and cardiovascular ailments. Personalized medicines are capable of being more effective in comparison with conventional types of treatment as they end up targeting the molecular and genetic basis of the conditions they address. Report Scope Feature of the Report Details Market Size in 2025 USD 66.13 Billion Projected Market Size in 2034 USD 252.93 Billion Market Size in 2024 USD 56.37 Billion CAGR Growth Rate 17.32% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product, Application, Technology, End-user and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Country Scope US Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the US Personalized Medicine report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the US Personalized Medicine report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the US Personalized Medicine Market Report @ SWOT Analysis Strengths: Genomic medicine is getting included in clinical practice. It is playing a vital role in diagnosing as well as treating the disease, thereby offering precise, individualized treatments providing better outcomes. Also, institutions are sharing data concerning clinical background, genetic information, and lifestyles across the providers, which facilitates the provision of more extensive and individualized treatment options, thereby helping to release new drugs in a faster way. Weaknesses: Tailored treatments such as sequencing, genetic tests, and targeted medications are costlier in comparison with conventional treatments. This factor does act as a substantial barrier to healthcare systems and insurance firms. Also, handling sensitive data does raise legal and ethical challenges pertaining to data privacy and security. These are some of the threats to the U.S. personalized medicine market. Opportunities: Amalgamating personalized medicine with digital health technologies such as remote monitoring and wearable devices is anticipated to improve patient engagement as well as treatment outcomes. Personalized medicine can also help in the identification of disease risks and promotion of preventive measures. Strategic partnerships amongst research organizations, academic institutions, and industry players have the ability to accelerate the adoption and development of personalized medicine. Threats: Lengthy processes of approvals and complicated regulatory requirements for personalized medicine products are likely to delay market access. The market players are bound to lose interest by the time the entire course of treatment or drugs gets approved and goes live. These are the major threats to the U.S. personalized medicine market. Request a Customized Copy of the US Personalized Medicine Market Report @ Key questions answered in this report: What is the size of the US Personalized Medicine market and what is its expected growth rate? What are the primary driving factors that push the US Personalized Medicine market forward? What are the US Personalized Medicine Industry's top companies? What are the different categories that the US Personalized Medicine Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the US Personalized Medicine market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium US Personalized Medicine Research Report | Fast Delivery Available - [220+ Pages] @ Key Developments The US personalized medicine market is witnessing a significant organic and inorganic expansion. Some of the key developments include – In May 2025, the scientists based in Philadelphia officiated a successful treatment for one of the rare genetic disorders in a nine-month-old baby using personalized CRISPR gene editing therapy. In January 2024, The US state of California announced that it would witness establishment of precision medicine center as the outcome of collaboration amongst the city of Bakersfield, the Kern Venture Group, and BIOS Health. The facility is bound to operate as a central location for R&D and brain clinical trials that use BIOS' adaptive dosage technology. In March 2023, Seagen announced that Pfizer acquired it for USD 229 in cash per Seagen share, totaling to USD 43 Billion enterprise value. Request a Customized Copy of the US Personalized Medicine Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'US Personalized Medicine Market Size, Trends and Insights By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, Liver, Rheumatology), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Genetics, Liquid Biopsy, Others (Predictive Modeling, Imaging)), By End-user (Hospitals, Diagnostic Centers, Research & Academic Institutes), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' Report at of the prominent players in the US Personalized Medicine Market: Illumina Inc. Precision Biologics Danaher Corporation (Cepheid Inc.) GE HealthCare Celera Diagnostics LLC Decode Genetics Inc. Exact Sciences Corporation IBM Corporation Exagen Inc. Biogen QIAGEN Genentech Inc. 23andMe Inc. Asuragen Inc. Others Click Here to Access a Free Sample Report of the US Personalized Medicine Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: Induced Pluripotent Stem Cell (iPSC) Market: Induced Pluripotent Stem Cell (iPSC) Market Size, Trends and Insights By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), By Application (Drug Development, Tissue Engineering & Regenerative Medicine, Disease Modelling, Toxicology Research), By End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Fabry Disease Treatment Market: Fabry Disease Treatment Market Size, Trends and Insights By Treatment (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), Others), By Route of Administration (Intravenous Route, Oral Route), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Elastomeric Infusions Pumps Market: Elastomeric Infusions Pumps Market Size, Trends and Insights By Product (Variable Rate, Continuous Rate), By Application (Antibiotic/Antiviral Therapy, Chemotherapy, Pain Management, Others), By End-Use (Ambulatory Surgical Centers, Hospitals, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Duchenne Muscular Dystrophy Drugs Market: Duchenne Muscular Dystrophy Drugs Market Size, Trends and Insights By Drug Type (Exon skipping drugs, Corticosteroids, Gene therapy, Other drug types), By Route of Administration (Oral, Injectable), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Digital Microscopes Market: Digital Microscopes Market Size, Trends and Insights By Product Type (Digital Biological Microscopes, Electron Microscope, Digital Surgical Microscopes, Others (Digital Inspection Camera, and Others)), By Modality (Desktop Digital Microscope, Portable Digital Microscope), By Connectivity (Wired Digital Microscope, Wireless Digital Microscope), By Application (Research & Development, Life Science, Medical Diagnostics, Forensic Testing), By End User (Hospitals, Clinics, Biopharmaceutical Companies, Academic Research Institute, Others (Forensic and Pathology Laboratory)), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Adult Day Care Services Market: Adult Day Care Services Market Size, Trends and Insights By Services (Adult Social Day Services, Adult Day Healthcare Services, Specialized Day Care Services), By Service Provider (Private, Public), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Synthetic Blood Substitutes and Blood Product Market: Synthetic Blood Substitutes and Blood Product Market Size, Trends and Insights By Source (Human Blood, Animal Blood, Synthetic Polymers, Stem Cells, Others), By Type (Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander), By Installation Type (Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Others), By End-User (Hospitals and Clinics, Blood Banks, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Dental Prosthetics Market: Dental Prosthetics Market Size, Trends and Insights By Type (Crowns, Bridges, Abutments, Dentures, Others), By End-User (Solo Practices, DSO/Group Practices, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 The US Personalized Medicine Market is segmented as follows: By Product Personalized Medicine Diagnostics Personalized Medicine Therapeutics Personalized Nutrition and Wellness By Application Oncology CNS Immunology Respiratory Liver Rheumatology By Technology Big Data Analytics Artificial Intelligence Bioinformatics Gene Sequencing Drug Discovery Companion Diagnostics Genetics Liquid Biopsy Others (Predictive Modeling, Imaging) By End-user Hospitals Diagnostic Centers Research & Academic Institutes Click Here to Get a Free Sample Report of the US Personalized Medicine Market @ This US Personalized Medicine Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Key Players in This US Personalized Medicine Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Market Status of the US Personalized Medicine Market? What Was the Capacity, Production Value, Cost and PROFIT of the US Personalized Medicine Market? What Is the Current Market Status of the US Personalized Medicine Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of US Personalized Medicine Market by Considering Applications and Types? What Are Projections of the US Personalized Medicine Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is US Personalized Medicine Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On US Personalized Medicine Industry? What are Macroeconomic Environment Analysis Results? What Are Macroeconomic Environment Development Trends? What Are Market Dynamics of US Personalized Medicine Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for US Personalized Medicine Industry? Click Here to Access a Free Sample Report of the US Personalized Medicine Market @ Reasons to Purchase US Personalized Medicine Market Report US Personalized Medicine Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. US Personalized Medicine Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. US Personalized Medicine Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. US Personalized Medicine Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the US Personalized Medicine market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium US Personalized Medicine Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide US Personalized Medicine market analysis. The competitive environment of current and potential participants in the US Personalized Medicine market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide US Personalized Medicine market should find this report useful. The research will be useful to all market participants in the US Personalized Medicine industry. Managers in the US Personalized Medicine sector are interested in publishing up-to-date and projected data about the worldwide US Personalized Medicine market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in US Personalized Medicine products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the US Personalized Medicine Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 737-734-2707 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium US Personalized Medicine Research Report | Fast Delivery Available - [220+ Pages] @ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-07-2025
- Yahoo
Regeneron Pharmaceuticals, Inc. (REGN) Acquires 23andMe Assets in $256M Deal
We recently compiled a list of Regeneron Pharmaceuticals, Inc. tops our list for being one of the most undervalued healthcare stocks. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the most undervalued stocks. It is a leading American biotech company specializing in treatments for serious diseases across ophthalmology, immunology, oncology, and rare conditions. The company is known for integrating genetics and technology into its drug discovery efforts and continues to grow through internal innovation and strategic acquisitions. In a major move, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is acquiring most of 23andMe's assets for $256 million, including its personal genome service, research services, biobank, and associated data. This will expand the business's access to genetic information from 15 million individuals (with 80% consenting to research use), enhancing its existing warehouse of 3 million anonymized samples. The acquisition significantly boosts Regeneron's capabilities in genetics-guided drug development and precision medicine. The vast dataset will help identify new drug targets, refine clinical trial designs, and improve patient stratification. This positions the corporation to lead the integration of real-world genomic data into personalized healthcare. A pharmacist at work in their online pharmacy checking over orders for pharmaceutical products. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) continues to advance its pipeline with FDA priority reviews for Dupixent (bullous pemphigoid) and Linvoseltamab (multiple myeloma), as well as promising late-stage results for EYLEA HD in eye disorders. The firm's focus remains on leveraging data and science to drive innovative, effective therapies. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data